搜尋結果
5 天前 · 概要. 基本信息. 药物类型. 预防性疫苗. 别名. Efluelda、FluQuadri、FluQuadri Junior. + [11] 靶点 - 作用机制. 免疫刺激剂. 治疗领域. 感染 呼吸系统疾病. 在研适应症. 流感病毒感染. 非在研适应症 - 原研机构. Sanofi Pasteur. 在研机构. Sanofi Pasteur 深圳赛诺菲巴斯德生物制品有限公司. 非在研机构 - 最高研发阶段 批准上市. 首次获批日期. 澳大利亚 (2014-12-02), 流感病毒感染. 最高研发阶段 (中国) 批准上市. 特殊审评 - 登录后查看首次获批时间轴. 关联.
4 天前 · Following its official market release of an innovative drug into the Chinese mainland market for the treatment of adults with insufficiently controlled type 2 diabetes mellitus, the company plans to invest hundreds of millions of yuan in the Beijing manufacturing site, Shi said.
3 天前 · Sanofi delivered close to double digit Q4 2020 business EPS growth at CER. Fourth quarter and full-year 2020 results were reviewed by management during a live audio webcast with the financial community. Fourth quarter and full-year 2020 results were followed by a virtual Capital Markets Day (CMD21). Q4 and FY 2020 results from Sanofi.
20 小時前 · Vaxigrip Tetra (Pháp) Vắc xin Vaxigrip Tetra được nghiên cứu và phát triển bởi tập đoàn dược phẩm Sanofi Pasteur (Pháp), phòng được 4 chủng virus cúm gồm: 2 chủng cúm A (H1N1, H3N2) và 2 chủng cúm B (Yamagata, Victoria).
3 天前 · Chinese tech giant Baidu announced on Monday that it has inked an agreement with Sanofi, a leading biopharmaceutical company focused on human health, to integrate Baidu's messenger ribonucleic acid (mRNA) design optimization platform, LinearDesign, into Sanofi's product design pipeline.
3 天前 · Sanofi is scheduled to introduce at least 25 new products into the China market by 2025, covering therapies in areas such as immunology, rare diseases, oncology, rare blood disorders, neurology, cardiovascular disease and diabetes, as well as vaccines.
2 天前 · Sanofi possède plusieurs laboratoires commercialisant des médicaments sous leur propre nom de marque, comme Sanofi Pasteur pour les vaccins, et compte plusieurs filiales principales : Sanofi Pasteur dans les vaccins ; Sanofi Genzyme dans les ; Sanofi R ;
